An Open Label Phase I Study to Evaluate the Safety and Tolerability of GI-6301 Vaccine Consisting of Whole, Heat-Killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express Brachyury Protein in Adults With Solid Tumors
Phase: PHASE1
Conditions: Neoplasms, Malignant Solid Tumors, Colon Neoplasms, Adenocarcinoma
Sponsor: National Cancer Institute (NCI)

N. Almodovar
N. Almodovar
1/7/16
AM I